Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

NCT05552755 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Adenomatous Polyposis

Interventions

DRUG: REC-4881
DRUG: Placebo

Sponsor

Recursion Pharmaceuticals Inc.